Drug Trials News for August 2021

Drug Trials News Archive

New RVC-Sanger research examines the impact of mass drug administration on the genome of a major parasitic disease New RVC-Sanger research examines the impact of mass drug administration on the genome of a major parasitic disease

A new study, produced in partnership between the Royal Veterinary College (RVC), the Wellcome Sanger Institute, Imperial College and the Vector Borne and Neglected Tropical Disease Control Division of the Ministry of Health, Uganda, has been published in Nature Communications. This research paves the way for a more effective genomic surveillance of schistosomiasis, a major human parasite. The study represents the largest fine-scale genomic investigation into the impact of repeated, long-term mass drug administration (MDA) of children and at-risk adults on populations of schistosome parasites.